美股A股
StockGist
Back
8-K2026-04-09· grok-4-1-fast-non-reasoning

ANTX · AN2 Therapeutics, Inc.

0001193125-26-149822

SEC filing

Summary

AN2 Therapeutics entered into a $80 million at-the-market sales agreement with Jefferies LLC and terminated its prior TD Cowen agreement after selling $20 million of common stock.

Key takeaways